Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2020 1
2021 3
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Case report: Regression of Glioblastoma after flavivirus infection.
Garcez PP, Guasti A, Ventura N, Higa LM, Andreiuolo F, de Freitas GPA, Ribeiro LJ, Maia RA, de Lima SMB, de Souza Azevedo A, Schwarcz WD, Caride EC, Chimelli L, Dubois LG, Ferreira Júnior ODC, Tanuri A, Moura-Neto V, Niemeyer P. Garcez PP, et al. Among authors: de souza azevedo a. Front Med (Lausanne). 2023 Jun 1;10:1192070. doi: 10.3389/fmed.2023.1192070. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37324152 Free PMC article.
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV.
Motta E, Camacho LAB, Cunha M, de Filippis AMB, Lima SMB, Costa M, Pedro L, Cardoso SW, Cortes FH, Giacoia-Gripp CBW, Morata M, Nazer S, Moreira RI, de Oliveira Souza MC, Mendes YS, Souza Azevedo A, Dos Santos Alvez N, Grinsztejn B, Coelho LE. Motta E, et al. Among authors: souza azevedo a. AIDS. 2023 Dec 1;37(15):2319-2329. doi: 10.1097/QAD.0000000000003696. Epub 2023 Aug 23. AIDS. 2023. PMID: 37650759 Free PMC article.
Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases.
Emi Aikawa N, Andrade Balbi V, Borba EF, Coracini Tonacio A, Maluf Elias Sallum A, Maria Arruda Campos L, Tomie Kozu K, Borges Vendramini M, Fontoura N, de Souza Azevedo A, Dias Schwarcz W, Marli Christovam Sartori A, Antonangelo L, Artur Silva C, Bonfá E. Emi Aikawa N, et al. Among authors: de souza azevedo a. Vaccine X. 2021 Dec 10;10:100131. doi: 10.1016/j.jvacx.2021.100131. eCollection 2022 Apr. Vaccine X. 2021. PMID: 34977552 Free PMC article.
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.
Tonacio AC, do Nascimento Pedrosa T, Borba EF, Aikawa NE, Pasoto SG, Filho JCRF, Sampaio Barros MM, Leon EP, Lombardi SCFS, Junior AM, Azevedo AS, Schwarcz WD, Fuller R, Yuki EFN, Ugolini Lopes MR, Rodrigues Pereira RM, Sampaio Barros PD, de Andrade DCO, de Medeiros-Ribeiro AC, de Moraes JCB, Shinjo SK, Miossi R, da Silva Duarte AJ, Lopes MH, Kallás EG, Almeida da Silva CA, Bonfá E. Tonacio AC, et al. Among authors: azevedo as. PLoS Negl Trop Dis. 2021 Nov 29;15(11):e0010002. doi: 10.1371/journal.pntd.0010002. eCollection 2021 Nov. PLoS Negl Trop Dis. 2021. PMID: 34843469 Free PMC article. Clinical Trial.
Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.
Azamor T, Horbach IS, Brito E Cunha D, Melgaço JG, Silva AMVD, Tubarão LN, Azevedo AS, Santos RT, Alves NDS, Machado TL, Silva J, Souza AF, Bayma C, Rocha VP, Frederico ABT, Dias BM, Setatino BP, Denani CB, Campos SPDC, Schwarcz WD, Sucupira MV, Mendes EP, Silva EDD, Barbosa de Lima SM, Ano Bom APD, Missailidis S. Azamor T, et al. Among authors: azevedo as. Viruses. 2022 Aug 30;14(9):1916. doi: 10.3390/v14091916. Viruses. 2022. PMID: 36146723 Free PMC article.
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Reis LR, Costa-Rocha IAD, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Costa-Pereira C, Otta DA, Freire LC, Lima SMB, Azevedo AS, Schwarcz WD, Ano Bom APD, Silva AMVD, Souza AF, Castro TDM, Ferroco CLV, Filippis AMB, Nogueira FB, Homma A, Domingues CM, Sousa ESS, Camacho LAB, Maia MLS, Teixeira-Carvalho A, Martins-Filho OA. Reis LR, et al. Among authors: azevedo as. Vaccine. 2022 Jan 31;40(5):798-810. doi: 10.1016/j.vaccine.2021.12.029. Epub 2021 Dec 27. Vaccine. 2022. PMID: 34969545
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.
Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, Fernandes EG, Sato HK, Fantinato FFST, Domingues CMAS, Kallás EG, Tomiyama HTI, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, Schwarcz WD, de Souza Azevedo A, Trindade GF, Ano Bom APD, da Silva AMV, Fernandes CB, Camacho LAB, de Sousa Maia ML; Collaborative Group for Studies of Yellow Fever Vaccine; Martins-Filho OA, do Antonelli LRDV. Abdala-Torres T, et al. Among authors: de souza azevedo a. NPJ Vaccines. 2024 Mar 8;9(1):54. doi: 10.1038/s41541-024-00836-w. NPJ Vaccines. 2024. PMID: 38459059 Free PMC article.
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.
da Penha Gomes Gouvea M, Lira Machado KLL, de Oliveira YGP, Moulaz IR, Henriques AG, Gouveia TM, Thompson BP, Lança KEM, de Souza Ramos S, Lacerda GCC, Lenzi JPG, de Castro Pimentel F, Miossi JPM, Rassele ML, Camacho LAB, Villela DAM, de Lima SMB, de Souza Azevedo A, Horbach IS, de Araújo MF, Tort LFL, de Oliveira ACA, Siqueira MM, Garcia CC, da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, da Silva VG, Miyamoto ST, Dos Santos Fantoni RN, Pinto-Neto LF, Magda Domingues C, de Medeiros Junior NF, Burian AP, Teixeira-Carvalho A, Mota LMH, Mill JG, Martins-Filho OA, Valim V. da Penha Gomes Gouvea M, et al. Among authors: de souza azevedo a. Vaccine. 2023 Oct 20;41(44):6514-6528. doi: 10.1016/j.vaccine.2023.08.022. Epub 2023 Sep 1. Vaccine. 2023. PMID: 37661534
Yellow fever neutralizing antibody seroprevalence proportion and titers in previously vaccinated adults with chronic kidney disease.
Cristina Martini Rodrigues C, Caroline Ribeiro Sales A, Marli Christovam Sartori A, de Souza Azevedo A, Maria Barbosa de Lima S, de Melo Picone C, Keiko Sato P, Nazareth Lara A, Takesaki Miyaji K, Sérgio Azevedo L, Caldin B, Camera Pierrotti L, Heloisa Lopes M. Cristina Martini Rodrigues C, et al. Among authors: de souza azevedo a. Vaccine. 2024 Mar 20:S0264-410X(24)00316-5. doi: 10.1016/j.vaccine.2024.03.029. Online ahead of print. Vaccine. 2024. PMID: 38514353
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.
Horbach IS, de Souza Azevedo A, Schwarcz WD, Alves NDS, de Moura Dias B, Setatino BP, da Cruz Moura L, de Souza AF, Denani CB, da Silva SA, Pimentel TG, de Oliveira Silva Ferreira V, Azamor T, Ano Bom APD, da Penha Gomes Gouvea M, Mill JG, Valim V, Polese J, Campi-Azevedo AC, Peruhype-Magalhães V, Teixeira-Carvalho A, Martins-Filho OA, de Lima SMB, de Sousa Junior IP. Horbach IS, et al. Among authors: de souza azevedo a. Diseases. 2024 Jan 18;12(1):29. doi: 10.3390/diseases12010029. Diseases. 2024. PMID: 38248380 Free PMC article.
12 results